U.S. Physical Therapy Logo
US90337L1089
923954
USPH

U.S. Physical Therapy

A carregar cotações...

Previsão

O preço-alvo médio dos analistas é € 81,09 (-10,15%). A mediana é € 81,09 (-10,15%).

Comprar
  10
Manter
  3
Vender
  0

Discussões na comunidade

Ainda não há nenhuma discussão sobre este ativo.

Iniciar discussão

  • U.S. Physical Therapy expands hospital alliances with NYU Langone to boost visits and reimbursement

    U.S. Physical Therapy is pursuing growth through clinic openings, acquisitions and hospital alliances, highlighted by a 10-year NYU Langone partnership that added 60 New York locations and yields flat per-visit payments with higher, more predictable reimbursement. The company opens about 25–30 clinics organically and acquires 30–70 annually using a local-partnership model that preserves clinician ownership and brands. Its injury-prevention unit has grown to roughly $120 million in revenue and more than $20 million in EBITDA, delivering margins about twice those of the physical therapy segment. Management reports about $220 million in debt, expects EBITDA above $100 million for the year, and has capital available for further expansion and share repurchases. » Mais em finance.yahoo.com


  • U.S. Physical Therapy relies on partnerships and Briotix to offset Medicare pressure

    U.S. Physical Therapy pursues a growth strategy based on a partnership model, hospital alliances (including an exclusive deal with NYU Langone) and expansion of its Briotix division to compensate for lower Medicare reimbursements and competition in the outpatient market. The NYU partnership is expected to bring about 700,000 additional treatments per year long term; Briotix generates roughly $120 million in revenue with substantially higher margins than the physical therapy business. Management views debt of about $220 million and expected EBITDA above $100 million as a manageable framework; it anticipates recoveries in Medicare reimbursement from 2024/2025 and stronger increases from 2028. » Mais em de.investing.com


  • Nchacha Etta to become CFO of U.S. Physical Therapy

    U.S. Physical Therapy appoints Nchacha Etta effective September 1, 2026, as executive vice president and chief financial officer. Etta previously served as CFO at Omnicell and held financial leadership roles at Essilor of America, Johnson & Johnson Vision and Coca‑Cola; he also sits on the board of directors of KBR. Jason Curtis will remain senior vice president for finance and accounting and will return to that role after serving as interim CFO. U.S. Physical Therapy operates 796 outpatient physical therapy clinics in 45 U.S. states. » Mais em de.investing.com


  • U.S. Physical Therapy expands into new U.S. state through acquisition

    U.S. Physical Therapy has acquired a physiotherapy group with 12 clinics, taking a 67% stake in the company while the previous owners retain 33%. The acquired group delivers about 112,000 treatments per year and generates annual revenue of USD 12 million. With the purchase, U.S. Physical Therapy increases its presence from 44 to 45 states and now operates 795 outpatient clinics; trailing twelve‑month revenue is USD 788 million. » Mais em de.investing.com


  • U.S. Physical Therapy misses Q1 2026 forecasts, stock falls

    U.S. Physical Therapy reported a GAAP loss per share of $0.12 for Q1 2026, missing the expected $0.54 by a wide margin; revenue was $198 million (expectation $200.26 million), a year‑over‑year increase of 7.9%. Weather‑related cancellations of roughly 31,000 patient appointments are estimated to have reduced revenue by about $3.3 million. The stock fell roughly 2% in after‑hours trading; management plans to push efficiency measures, virtualize reception areas, implement AI‑assisted documentation, and expand self‑pay offerings. » Mais em de.investing.com

Em 2026, U.S. Physical Therapy já distribuiu € 1,19 em dividendos. A última distribuição ocorreu em setembro.

Dados financeiros da empresa

No último trimestre, U.S. Physical Therapy registou receitas de € 196,49 mi e um ganho líquido de € 9,75 mi
(EUR) setembro de 2026
YoY
Receitas 196,49 mi 40,58%
Ganho bruto 37,99 mi 20,91%
Ganho líquido 9,75 mi 57,99%
EBITDA 27,71 mi 4,52%

Dados fundamentais

Métrica Valor
Capitalização bolsista
€ 1,33 bi
Número de ações
14,93 mi
Máximo/mínimo de 52 semanas
€ 91,16 - € 52,43
Rentabilidade de dividendos
1,74%
Dividendos TTM
€ 1,57
Próximo dividendo
€ 0,41
Beta
1,13
PER (PE Ratio)
-73,51
PEG (PEG Ratio)
0,47
P/VC (PB Ratio)
3,45
P/V (PS Ratio)
1,77

Perfil da empresa

A U.S. Physical Therapy, Inc., através das suas subsidiárias, opera clínicas de fisioterapia ambulatória que prestam cuidados pré e pós-operatórios e tratamento para perturbações ortopédicas, lesões relacionadas com o desporto, cuidados preventivos, reabilitação de trabalhadores lesionados e lesões de origem neurológica. A empresa opera através de dois segmentos, Physical Therapy Operations e Industrial Injury Prevention Services. A empresa oferece serviços de prevenção de lesões industriais, incluindo prevenção e reabilitação de lesões no local de trabalho, otimização do desempenho, testes de emprego pós-oferta, avaliações da capacidade funcional e avaliações ergonómicas, através de fisioterapeutas e treinadores desportivos certificados especializados, para empresas da Fortune 500 e outros clientes, entre os quais seguradoras e os seus prestadores de serviços. A 31 de dezembro de 2021, a empresa explorava 591 clínicas em 39 estados e geria 35 unidades de prática de fisioterapia. A empresa foi fundada em 1990 e tem sede em Houston, Texas.

Nome
U.S. Physical Therapy
CEO
Christopher J. Reading
Sede Houston, tx
EUA
Site
Setor
Cuidados de saúde
Indústria
Cuidados de saúde: prestadores e serviços
Entrada em bolsa
29/05/1992
Colaboradores 6.374

Símbolos de ticker

Bolsa Símbolo
NYSE
USPH
Frankfurt
UPH.F
Düsseldorf
UPH.DU
🍪

Parqet  utiliza cookies. Saber mais